Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lindsay Devane

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Pharmacotherapy|September 22, 2016
Women's Pharmacotherapy MattersC Lindsay DeVane
Pharmacotherapy|May 5, 2023
Current clinical pharmacology issues in pregnancy and pediatricsC Lindsay DeVane
Pharmacotherapy|February 3, 2023
Reflections on the future of biomedical publishingC Lindsay DeVane
Pharmacotherapy|January 30, 2015
In her own words: Jean Nappi, ACCP President, 1994-1995Jean Nappi, C Lindsay DeVane
Psychopharmacology Bulletin|May 8, 2004
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an updateC Lindsay DeVane, Jacob Mintzer
Psychopharmacology Bulletin|October 17, 2003
Pharmacokinetics and drug interactions of the sedative hypnoticsJun-Sheng Wang, C Lindsay DeVane
CNS Spectrums|May 8, 2004
Great expectations in stereochemistry: focus on antidepressantsC Lindsay DeVane, David W Boulton
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitroJun-Sheng Wang, C Lindsay DeVane
Pharmacotherapy|September 19, 2023
Standards of practice to advance the quality of health careC Lindsay DeVane, Jerry L Bauman
Psychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S Markowitz
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Pharmacotherapy|September 22, 2016
Women's Pharmacotherapy MattersC Lindsay DeVane
Pharmacotherapy|May 5, 2023
Current clinical pharmacology issues in pregnancy and pediatricsC Lindsay DeVane
Pharmacotherapy|February 3, 2023
Reflections on the future of biomedical publishingC Lindsay DeVane
Pharmacotherapy|January 30, 2015
In her own words: Jean Nappi, ACCP President, 1994-1995Jean Nappi, C Lindsay DeVane
Psychopharmacology Bulletin|May 8, 2004
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an updateC Lindsay DeVane, Jacob Mintzer
Psychopharmacology Bulletin|October 17, 2003
Pharmacokinetics and drug interactions of the sedative hypnoticsJun-Sheng Wang, C Lindsay DeVane
CNS Spectrums|May 8, 2004
Great expectations in stereochemistry: focus on antidepressantsC Lindsay DeVane, David W Boulton
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitroJun-Sheng Wang, C Lindsay DeVane
Pharmacotherapy|September 19, 2023
Standards of practice to advance the quality of health careC Lindsay DeVane, Jerry L Bauman
Psychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S Markowitz
Pageof 10